Electromed (ELMD) director reports 3,000-share restricted stock grant on Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Electromed, Inc. reported a Form 4 insider transaction for a company director. On 12/01/2025, the director acquired 3,000 shares of common stock, coded as an "A" transaction, at a reported price of $0, indicating a grant rather than an open-market purchase. These shares are described as restricted stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated under their terms.
Following this grant, the director beneficially owned 21,000 shares of Electromed common stock in direct form. The filing is made by a single reporting person in the capacity of Director of Electromed.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Fluet Gregory
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,000 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 21,000 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Electromed (ELMD) report in this Form 4?
Electromed reported that a company director acquired 3,000 shares of common stock on 12/01/2025, shown as an "A" (acquired) transaction at a reported price of $0.
What is the director’s relationship to Electromed (ELMD) in this filing?
The reporting person is identified as a Director of Electromed, Inc., with the Form 4 indicating it was filed by one reporting person.
Was this Electromed (ELMD) Form 4 filed jointly with other insiders?
No. The form indicates it is filed by one reporting person, not by more than one reporting person.
Does this Electromed (ELMD) Form 4 involve any derivative securities?
No derivative securities are listed in Table II; the reported activity involves non-derivative common stock only.